Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies that have the potential to transform patient care and improve quality of life. We consider a broad range of therapeutic areas being developed at both pre-clinical and clinical stage companies, prioritizing growth potential and areas of unmet medical need.

We strive to be the partner of choice for life sciences companies and their existing investors, providing significant capital, personalized attention and strategic growth support to ensure each company realizes its true potential.